Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Jan 23, 2026

Total Value ($000): $834,980 (100.0% shares, 0.0% debt)

Holdings (5)

Unchanged Positions (5)

PHAT PHATHOM PHARMACEUTICALS INC 14.8%

Value ($000) $123,837 Shares 7,464,572 Est. Cost $13.72 Unrealized +4.1%

— RAPT THERAPEUTICS INC 11.3%

Value ($000) $94,633 Shares 2,794,000 Est. Cost $25.79 Unrealized —

NAMS NEWAMSTERDAM PHARMA COMPANY 12.1%

Value ($000) $100,664 Shares 2,869,565 Est. Cost $10.96 Unrealized +232.2%

CNTA CENTESSA PHARMACEUTICALS PLC 59.8%

Value ($000) $499,279 Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 2.0%

Value ($000) $16,567 Shares 3,039,892 Est. Cost $17.87 Unrealized -66.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$123,837	14.8%	$13.72	+4.1%	COM	71722W107
—	RAPT THERAPEUTICS INC	2,794,000	$94,633	11.3%	$25.79	—	COM	75382E109
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$100,664	12.1%	$10.96	+232.2%	ORDINARY SHARES	N62509109
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$499,279	59.8%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$16,567	2.0%	$17.87	-66.8%	COM	05153U107